We are live on ! Find out more
LSTA icon

Lisata Therapeutics
LSTA

52 hedge funds and large institutions have $9.14M invested in Lisata Therapeutics in 2015 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 12

22% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 9

4% more funds holding

Funds holding: 50 → 52 (+2)

33% less capital invested

Capital invested by funds: $13.6M → $9.14M (-$4.45M)

57% less call options, than puts

Call options by funds: $109K | Put options by funds: $255K

Holders
52
Holders Change
+2
Holders Change %
+4%
% of All Funds
1.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
15
Reduced
12
Closed
9
Calls
$109K
Puts
$255K
Net Calls
-$146K
Net Calls Change
+$521K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$223K
2
OC
Oppenheimer & Co
New York
+$207K
3
State Street
State Street
Massachusetts
+$175K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$162K
5
BFA
BlackRock Fund Advisors
California
+$152K

Top Sellers

Rank Fund Capital Flow
1
Group One Trading
Group One Trading
Illinois
-$349K
2
SIP
Stoneridge Investment Partners
Pennsylvania
-$307K
3
Millennium Management
Millennium Management
New York
-$258K
4
RJA
Raymond James & Associates
Florida
-$250K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$226K
Name Holding Trade Value Shares
Change 		Change in
Stake
NFA
26
Nationwide Fund Advisors
Ohio
$46K – – –
CG
27
Caprock Group
Idaho
$43K – – –
PP
28
Paloma Partners
Connecticut
$43K +$61.3K +113 New
AIG
29
American International Group
New York
$37.8K – – –
Group One Trading
30
Group One Trading
Illinois
$37K -$349K -643 -87%
CS
31
Credit Suisse
Switzerland
$35K -$123K -227 -71%
Millennium Management
32
Millennium Management
New York
$32K -$258K -476 -85%
GC
33
Guggenheim Capital
Illinois
$30K +$4.88K +9 +13%
BA
34
BlackRock Advisors
Delaware
$29K +$4.88K +9 +13%
Bank of America
35
Bank of America
North Carolina
$19K +$7.05K +13 +35%
UBS Group
36
UBS Group
Switzerland
$16K +$13.6K +25 +139%
Citigroup
37
Citigroup
New York
$10K -$10.8K -20 -44%
TRCT
38
Tower Research Capital (TRC)
New York
$9K +$12.5K +23 New
AllianceBernstein
39
AllianceBernstein
Tennessee
$7K – – –
IWMPD
40
Integrated Wealth Management (Palm Desert)
California
$7K +$10.8K +20 New
Creative Planning
41
Creative Planning
Kansas
$5K – – –
LTFS
42
Ladenburg Thalmann Financial Services
Florida
$5K +$4.88K +9 +900%
Fifth Third Bancorp
43
Fifth Third Bancorp
Ohio
$5K +$7.05K +13 New
JIC
44
Joel Isaacson & Co
New York
$4K – – –
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
$3K -$226K -416 -98%
Wells Fargo
46
Wells Fargo
California
$3K -$5.42K -10 -53%
BNP Paribas Financial Markets
47
BNP Paribas Financial Markets
France
$1.46K +$2.17K +4 New
Barclays
48
Barclays
United Kingdom
$1K -$2.17K -4 -44%
PRCM
49
Pine River Capital Management
Minnesota
$1K – – –
SIA
50
Stancorp Investment Advisers
Oregon
$1K – – –
1
2
3

LSTA Hedge Fund Activity: Q1 2015 in Review

52 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Lisata Therapeutics (LSTA) for Q1 2015, worth a combined $9.14M — down 33% from $13.6M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new LSTA positions and 9 closed out — a net gain of 2 holders — while 15 added to existing stakes and 12 trimmed.

The largest buyer was Vanguard Group, adding an estimated $223K. The largest seller was Group One Trading, cutting an estimated $349K.

  • 52 institutional investors held Lisata Therapeutics (LSTA) as of Q1 2015, up from 50 in Q4 2014.
  • Funds reported $9.14M of Lisata Therapeutics stock for Q1 2015, down 33% quarter-over-quarter.
  • 11 funds opened new Lisata Therapeutics positions in Q1 2015 and 9 closed out, a net change of +2 holders.
  • The largest Lisata Therapeutics buyer in Q1 2015 was Vanguard Group, an estimated $223K added.
  • The largest Lisata Therapeutics seller in Q1 2015 was Group One Trading, an estimated $349K sold.

Based on aggregated 13F filings for Q1 2015.